MODERN REPRESENTATION OF TRANSUYULAR PORTHOSYSTEM SHUNTING
Abstract
The article is a literature review of the use of transjugular intrahepatic portosystemic shunting (TIPS) in patients with cirrhosis of the liver. A historical reference is given on the formation of the method and the theoretical justification for its application. The indications and contraindications to the TIPS are considered, the most common complications after the TIPS are mentioned.
About the Authors
A. V. Kovalev
Krasnoyarsk state medical University im. professor V. F. Voyno-Yasenetsky ministry of health of Russia
Russian Federation
Russian Federation
G. E. Karapetyan
Krasnoyarsk state medical University im. professor V. F. Voyno-Yasenetsky ministry of health of Russia
Russian Federation
Russian Federation
S. S. Dunaevskaya
Krasnoyarsk state medical University im. professor V. F. Voyno-Yasenetsky ministry of health of Russia
Russian Federation
Russian Federation
R. A. Pakhomova
Krasnoyarsk state medical University im. professor V. F. Voyno-Yasenetsky ministry of health of Russia
Russian Federation
Russian Federation
L. V. Kochetova
Krasnoyarsk state medical University im. professor V. F. Voyno-Yasenetsky ministry of health of Russia
Russian Federation
Russian Federation
References
1. Blachier M., Leleu H., Peck-Radosavljevic M. et al. The burden of liver disease in Europe: a review of available epidemiological data // J. Hepa- tol. 2013. Vol. 58. № 3. P. 593-608
2. Henry J.A., Moloney C., Rivas C., Goldin R.D. Increase in alcohol related deaths: is hepatitis Cafactor? // J. Clin. Pathol. 2002. Vol. 55. № 9. P. 704-707
3. Kowdley K.V., Wang C.C., Welch S. et al. Prevalence of chronic hepatitis B among foreign-born persons living in the United States by coun- try of origin // Hepatology. 2012. Vol. 56. № 2. P. 422-433
4. Vierling J.M., Zeuzem S., Poordad F. et al. Safety and efficacy of boceprevir/peginterferon/ribavirin for HCV G1 compensated cirrhotics: meta-analysis of 5 trials // J. Hepatol. 2014. Vol. 61. № 2. P. 200-209
5. Bakulin I., Pasechnikov V., Varlamicheva A., Sannikova I. nS3 protease inhibitors for treatment of chronic hepatitis C: Efficacy and safety // World J. Hepatol. 2014. Vol. 6. № 5. P. 326-339
6. Afdhal N.H., Dusheiko G.M., Giannini E.G. et al. Eltrombopag in- creases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapy // Gastroenterology. 2014. Vol. 146. № 2. P. 442-452
7. Бакулин И.Г., Хайменова Т.Ю., Сидорова И.О. Лечение больных с циррозом печени HBV-этиологии: успехи, нерешенные вопросы // Терапевтический архив. 2013. Т. 85. № 12. С. 114-118
8. Dienstag J.L. Hepatitis B virus infection // n. Engl. J. Med. 2008. Vol. 359. № 14. P. 1486-1500
9. Lok A.S., McMahon B.J. Chronic hepatitis B: update 2009 // Hepa- tology. 2009. Vol. 50. № 3. P. 661-662
10. Marcellin P., Gane E., Buti M. et al. Regression of cirrhosis du- ring treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study // Lancet. 2013. Vol. 381. № 9865. P. 468-475
11. Liaw Y.F., Raptopoulou-Gigi M., Cheinquer H. et al. Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with he- patic decompensation: a randomized, openlabel study // Hepatology. 2011. Vol. 54. № 1. P. 91-100
12. Sanyal A.J., Boyer T., Garcia-Tsao G. et al. A randomized, prospec- tive, double-blind, placebo-controlled trial of terlipressin for type 1 hepa- torenal syndrome // Gastroenterology. 2008. Vol. 134. № 5. P. 1360-1368
13. Runyon B.A., AASLD Practice Guidelines Committee. Manage- ment of adult patients with ascites due to cirrhosis: an update // Hepatology. 2009. Vol. 49. № 6. P. 2087-2107
14. Бакулин И.Г., Сандлер Ю.Г. Цирроз печени: что нового в ле- чении // Эффективная фармакотерапия. 2014. № 43. С. 42-50
15. Затевахин И.И., Цициашвили М.Х., Шиповский В.Н., Мо- нахов Д.В., Шагинян А.К., Мызников И.В. Малоинвазивные мето- ды лечения осложнений портальной гипертензии // Вестник хирур- гической гастроэнтерологии. - 2009. - № 2. - С.4-11
16. Котив Б.Н., Дзидзава И.И., Алентьев С.А. Портокавальное шунтирование в лечении больных циррозом печени с синдромом портальной гипертензии // Анналы хирургической гепатологии. - 2008. - Т.13, № 4. - С.76-80
17. Хоронько Ю.В., Микрюков В.А. Прогнозирование исходов операций порто-системного шунтирования при портальной гипер- тензии, осложненной варикозным пищеводным кровотечением // Вестник экспериментальной и клинической медицины. - 2014. - Прил.1. - С.32
18. Шерцингер А.Г., чжао А.В., Ивашкин В.Т. [и др.]. Лечение кровотечений из варикозно расширенных вен пищевода и желудка // Анналы хирургической гепатологии. - 2013. - Т.18, no. 3. - С.110-129
19. Cat T.B., Liu-DeRyke X. Medical management of variceal hemor- rhage // Crit Care nurs Clin north Am. 2010. - Vol. 22. - no. 3. - Р. 381- 393
20. Cholongitas E., Papatheodoridis G.V., Vangeli M., Terreni N., Patch D., Burroughs A.K. Systematic review: the model for end-stage liver disease - should it replace Child-Pugh’s classification for assessing prog- nosis in cirrhosis? // Aliment Pharmacol Ther. - 2005. - Vol.22, no.11-12. - P.1079-1089
21. Christensen E. Prognostic models including the Child-Pugh, MELD and Mayo risk scores - where are we and where should we go? // Journal of Hepatology. - 2004. - V.41. - P.344-350
22. Frye J.W., Perri R.E. Perioperative risk assessment for patients with cirrhosis and liver disease // Expert Rev Gastroenterol Hepatol. - 2009. - Vol.3, no.1. - P.65-75
23. Garcia-Tsao G., Sanyal A.J., Grace N.D., Carey W.D. Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis // Am J Gastroenterol. 2007. - no.102. - P.2086-2102
24. Wang M.T., Liu T., Ma X.Q., He J. Prognostic factors associated with rebleeding in cirrhotic inpatients complicated with esophageal variceal bleeding / /Chin Med J (Engl). 2011. - Vol. 124. - no.10. - Р. 1493-1497
Review
For citations:
Kovalev A.V., Karapetyan G.E., Dunaevskaya S.S., Pakhomova R.A., Kochetova L.V. MODERN REPRESENTATION OF TRANSUYULAR PORTHOSYSTEM SHUNTING. Moscow Surgical Journal. 2017;(6):32-34. (In Russ.)
Views:
334
Email this article 